[Diabetes and COVID-19 in the elderly, harmful symbiosis].
作者信息
Formiga Francesc, Tarazona-Santabalbina Francisco José
机构信息
Servicio de Medicina Interna, Hospital de Bellvitge, ĹHospitalet de Llobregat, Barcelona, España.
Servicio de Geriatría, Hospital Universitario de la Ribera, Alzira, Valencia, España.
出版信息
Rev Esp Geriatr Gerontol. 2020 Nov-Dec;55(6):315-316. doi: 10.1016/j.regg.2020.07.006. Epub 2020 Aug 18.
Abstract
摘要
相似文献
1
[Diabetes and COVID-19 in the elderly, harmful symbiosis].[老年人中的糖尿病与新冠病毒病，有害共生关系]
Rev Esp Geriatr Gerontol. 2020 Nov-Dec;55(6):315-316. doi: 10.1016/j.regg.2020.07.006. Epub 2020 Aug 18.
2
COVID-19 and cardiovascular disease.新型冠状病毒肺炎与心血管疾病。
Clin Investig Arterioscler. 2020 Nov-Dec;32(6):263-266. doi: 10.1016/j.arteri.2020.10.005.
3
Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics.COVID-19 中的组织蛋白酶 L：从药理学证据到遗传学。
Front Cell Infect Microbiol. 2020 Dec 8;10:589505. doi: 10.3389/fcimb.2020.589505. eCollection 2020.
4
Diabetes mellitus: Lessons from the COVID-19 pandemic.糖尿病：来自COVID-19大流行的经验教训。
Hellenic J Cardiol. 2020 Jan-Feb;61(1):1-2. doi: 10.1016/j.hjc.2020.03.009. Epub 2020 May 18.
5
Platelets and renal failure in the SARS-CoV-2 syndrome.血小板与 SARS-CoV-2 综合征所致肾衰竭。
Platelets. 2021 Jan 2;32(1):130-137. doi: 10.1080/09537104.2020.1817361. Epub 2020 Sep 6.
6
Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?血管紧张素转换酶 2 的调节：预防 COVID-19 的潜在靶点？
Front Endocrinol (Lausanne). 2021 Oct 22;12:725967. doi: 10.3389/fendo.2021.725967. eCollection 2021.
7
Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.血管紧张素转换酶 2 和肾素血管紧张素系统抑制剂在 COVID-19 中的应用：最新进展。
High Blood Press Cardiovasc Prev. 2021 Mar;28(2):129-139. doi: 10.1007/s40292-021-00439-9. Epub 2021 Feb 26.
8
Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms.血管紧张素转化酶 2、COVID-19 和腹主动脉瘤。
J Vasc Surg. 2021 Nov;74(5):1740-1751. doi: 10.1016/j.jvs.2021.01.051. Epub 2021 Feb 15.
9
A potential therapeutic combination for treatment of COVID-19: Synergistic effect of DPP4 and RAAS suppression.一种治疗 COVID-19 的潜在治疗组合：DPP4 和 RAAS 抑制的协同作用。
Med Hypotheses. 2020 Nov;144:110186. doi: 10.1016/j.mehy.2020.110186. Epub 2020 Aug 14.
10
Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?在新冠疫情期间，血管紧张素受体阻断药物是否可能有害？
J Hypertens. 2020 May;38(5):781-782. doi: 10.1097/HJH.0000000000002450.
本文引用的文献
1
[Solving one of the pieces of the puzzle: COVID-19 and type 2 diabetes].[解决谜题的其中一块：2019冠状病毒病与2型糖尿病]
Rev Clin Esp. 2020 Nov;220(8):507-510. doi: 10.1016/j.rce.2020.05.003. Epub 2020 May 18.
2
The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 Subjects.年龄对 COVID-19 患者死亡率的影响：一项纳入 611583 例患者的荟萃分析。
J Am Med Dir Assoc. 2020 Jul;21(7):915-918. doi: 10.1016/j.jamda.2020.05.045. Epub 2020 May 25.
3
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.新型冠状病毒病 2019（COVID-19）的病理生理学、传播、诊断和治疗：综述。
JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839.
4
[Differences in anxiety, sadness, loneliness and comorbid anxiety and sadness as a function of age and self-perceptions of aging during the lock-out period due to COVID-19].[因 COVID-19 封锁期导致的焦虑、悲伤、孤独以及共病焦虑和悲伤随年龄及衰老自我认知的变化]
Rev Esp Geriatr Gerontol. 2020 Sep-Oct;55(5):272-278. doi: 10.1016/j.regg.2020.05.005. Epub 2020 Jun 4.
5
Corticosteroids in diabetes patients infected with COVID-19.感染新型冠状病毒肺炎的糖尿病患者使用皮质类固醇的情况。
Ir J Med Sci. 2021 Feb;190(1):29-31. doi: 10.1007/s11845-020-02287-3. Epub 2020 Jun 25.
6
[Evolution and treatment of storm cytoquine syndrome associated to SARS-CoV-2 infection among octogenarians].[老年人群中与SARS-CoV-2感染相关的暴发性细胞因子综合征的演变与治疗]
Rev Esp Geriatr Gerontol. 2020 Sep-Oct;55(5):286-288. doi: 10.1016/j.regg.2020.05.004. Epub 2020 Jun 3.
7
COVID-19 pandemic and mental health consequences: Systematic review of the current evidence.COVID-19 大流行及其对心理健康的影响：当前证据的系统综述。
Brain Behav Immun. 2020 Oct;89:531-542. doi: 10.1016/j.bbi.2020.05.048. Epub 2020 May 30.
8
Is DPP4 inhibition a comrade or adversary in COVID-19 infection.DPP4 抑制剂在 COVID-19 感染中是战友还是敌人。
Diabetes Res Clin Pract. 2020 Jun;164:108216. doi: 10.1016/j.diabres.2020.108216. Epub 2020 May 19.
9
Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis.糖尿病与2019冠状病毒病的死亡率及严重程度相关吗？一项荟萃分析。
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):535-545. doi: 10.1016/j.dsx.2020.04.044. Epub 2020 May 6.
10
SARS-CoV-2 and DPP4 inhibition: Is it time to pray for Janus Bifrons?SARS-CoV-2 和 DPP4 抑制：是时候祈求两面神了吗？
Diabetes Res Clin Pract. 2020 May;163:108162. doi: 10.1016/j.diabres.2020.108162. Epub 2020 Apr 23.
Zotero 插件